Praxis Precision Company Insiders
PRAX Stock | USD 70.54 0.29 0.41% |
Praxis Precision's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Praxis Precision Medicines suggests that vertually all insiders are panicking. Praxis Precision employs about 82 people. The company is managed by 12 executives with a total tenure of roughly 192 years, averaging almost 16.0 years of service per executive, having 6.83 employees per reported executive.
Praxis Precision's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-11-14 | Lauren Mastrocola | Disposed 5188 @ 81.78 | View |
Monitoring Praxis Precision's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Praxis |
Praxis Precision Management Team Effectiveness
The company has return on total asset (ROA) of (0.392) % which means that it has lost $0.392 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6434) %, meaning that it created substantial loss on money invested by shareholders. Praxis Precision's management efficiency ratios could be used to measure how well Praxis Precision manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.69 in 2025. Return On Capital Employed is likely to drop to -2.11 in 2025. At this time, Praxis Precision's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 108.3 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 3 M in 2025.Common Stock Shares Outstanding is likely to rise to about 8 M in 2025, despite the fact that Net Loss is likely to grow to (183 M).
Praxis Precision Workforce Comparison
Praxis Precision Medicines is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,002. Praxis Precision holds roughly 82.0 in number of employees claiming about 4% of equities under Health Care industry.
Praxis Precision Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Praxis Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Praxis Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Praxis Precision insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 1.1429 | 8 | 7 | 198,750 | 2,342 |
2024-12-01 | 1.0 | 4 | 4 | 12,456 | 25,385 |
2024-03-01 | 0.5714 | 4 | 7 | 172,000 | 1,051 |
2023-03-01 | 1.75 | 14 | 8 | 1,330,147 | 17,100 |
2022-03-01 | 3.0 | 12 | 4 | 756,000 | 5,629 |
2021-09-01 | 0.25 | 2 | 8 | 13,447 | 460,832 |
2021-06-01 | 9.0 | 9 | 1 | 397,829 | 2,700,000 |
2021-03-01 | 11.0 | 11 | 1 | 561,292 | 45,000 |
2020-12-01 | 0.3654 | 19 | 52 | 23,708,512 | 54,872,218 |
Praxis Precision Notable Stakeholders
A Praxis Precision stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Praxis Precision often face trade-offs trying to please all of them. Praxis Precision's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Praxis Precision's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Marcio MBA | CEO President | Profile | |
Dr B | CoFounder Officer | Profile | |
Timothy Kelly | CFO Treasurer | Profile | |
Nicole Sweeny | Chief Officer | Profile | |
Kelly McCue | Chief Officer | Profile | |
Alyssa Wyant | Chief Officer | Profile | |
Megan Sniecinski | Chief Officer | Profile | |
Lauren Mastrocola | VP Officer | Profile | |
Brian Spar | Chief Staff | Profile | |
Alex JD | General Secretary | Profile | |
Karl Hansen | Chief Officer | Profile | |
Alex Kane | VP Communications | Profile |
About Praxis Precision Management Performance
The success or failure of an entity such as Praxis Precision Med often depends on how effective the management is. Praxis Precision management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Praxis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Praxis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.61) | (1.69) | |
Return On Capital Employed | (2.01) | (2.11) | |
Return On Assets | (1.61) | (1.69) | |
Return On Equity | (2.03) | (2.14) |
Please note, the imprecision that can be found in Praxis Precision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Praxis Precision Medicines. Check Praxis Precision's Beneish M Score to see the likelihood of Praxis Precision's management manipulating its earnings.
Praxis Precision Workforce Analysis
Traditionally, organizations such as Praxis Precision use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Praxis Precision within its industry.Praxis Precision Manpower Efficiency
Return on Praxis Precision Manpower
Revenue Per Employee | 29.8K | |
Revenue Per Executive | 203.9K | |
Net Loss Per Employee | 1.5M | |
Net Loss Per Executive | 10.3M | |
Working Capital Per Employee | 843.1K | |
Working Capital Per Executive | 5.8M |
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.